REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Vincze-Pharma Bt. (Hungary)

Main Activities: Pharmacies and Drug Stores
Full name: VINCZE-PHARMA Gyogyszer Kereskedelmi Bt. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Vincze-Pharma Bt. is an enterprise based in Hungary. Its main office is in Gyure. The company operates in the Pharmacies and Drug Stores sector. The enterprise was incorporated on November 24, 1995. The total number of employees is currently 5 (2024). The company’s latest financial report indicates a net sales revenue drop of 0.67% in 2023. Its’ total assets recorded a growth of 0.14%. In 2023, Vincze-Pharma Bt.’s net profit margin decreased by 2.36%.

Headquarters
Bessenyei u. 2.
Gyure; Szabolcs-Szatmar-Bereg; Postal Code: 4813

Contact Details: Purchase the Vincze-Pharma Bt. report to view the information.

Basic Information
Total Employees:
Purchase the Vincze-Pharma Bt. report to view the information.
Outstanding Shares:
Purchase the Vincze-Pharma Bt. report to view the information.
Registered Capital:
Purchase the Vincze-Pharma Bt. report to view the information.
Incorporation Date:
November 24, 1995
Key Executives
Purchase this report to view the information.
Business Manager
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Viridis-Pharma Kft.
Company Performance
Financial values in the chart are available after Vincze-Pharma Bt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-0.67%▼
Total operating revenue
-2.41%▼
Operating profit (EBIT)
-43.28%▼
EBITDA
-36.45%▼
Net Profit (Loss) for the Period
-52.8%▼
Total assets
0.14%▲
Total equity
-35.56%▼
Operating Profit Margin (ROS)
-2.27%▼
Net Profit Margin
-2.36%▼
Return on Equity (ROE)
-10.75%▼
Quick Ratio
-0.69%▼
Cash Ratio
-0.26%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo